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Dear Editor, 
 
Recently, Magkrioti and colleagues published a study about the autotaxin-lysophosphatidic 
acid axis in lung cancer (Magkrioti et al., 2018). Autotaxin (ATX, ENPP2), a secreted glyco-
protein that cleaves extracellular lysophosphatidylcholine to generate LPA, is the most relevant 
factor of extracellular lysophosphatidic acid (LPA) production. LPA is known to activate LPA 
receptors (LPAR), G-protein coupled receptors that show a widespread distribution and are 
expressed on many tumor cells (Schleicher et al., 2011; Jonkers and Moolenaar, 2009; Lin et 
al., 2010; Yu et al., 2016). Magkrioti et al. (2018) demonstrated that a phospholipid phosphatase 
(LPPP3) that further metabolizes LPA was downregulated in patients with lung cancer, which 
may lead to increased intratumoral LPA. Moreover, genetic deletion of autotaxin as well as the 
LPA receptor Lpar1 attenuated tumor growth in mouse models of lung cancer (Magkrioti et al., 
2018). 
The role of extracellular LPA in tumor development is well established (Okabe et al., 2011; 
Leblanc et al., 2018; Stuelten et al., 2018; Bailey et al., 2017; Fukushima et al., 2017). However, 
recently, evidence has been presented that also intracellular LPA influences the tumor pheno-
type by enhancing tumor cell migration (Stewart et al., 2012; Hassan, 2017; Lesjak et al., 2014; 
Marchan et al., 2012). The intracellular glycerophosphocholine phosphodiesterase EDI3 
(GDE5, GDPD6, or GPCPD1) hydrolyzes the glycerophosphodiester glycerophosphocholine 
(GPC) to glycerol-3-phosphate (G3P) and choline (Marchan et al., 2017; Stewart et al., 2012). 
G3P is further metabolized to LPA by glycerol-3-phosphate acyltransferase (GPAM). Recently, 
it has been shown that knockdown of GPAM decreases, while overexpression increases tumor 
cell migration (Marchan et al., 2017). These changes in migration correspond to altered intra-
cellular LPA concentrations (Marchan et al., 2017).  
It still remains open by which mechanism intracellular LPA influences the phenotype of 
tumor cells. Does it act on endocytozed LPA receptors? Or are there so far unidentified inter-
action partners? Tumor development represents a complex process where control factors of 
proliferation (Schmidt et al., 2008; Cadenas et al., 2014; Hellwig et al., 2016), interactions with 
the immune system (Schmidt et al., 2012, 2018; Heimes et al., 2017a, b) and redox factors 
(Cadenas et al., 2010; Jabs et al., 2017) play a key role. Research how phospholipid metabolism 
contributes to this complex process is still at its infancy.  
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